A report indicates ongoing demand for COVID-19 vaccines and other biologics, as well as increasing investment will drive a 16.6 percent CAGR in the bioreactors market.
List view / Grid view
Moving towards the digitalisation of your lab, with the 8th edition of the Paperless Lab Academy® – this year, online
Master your eData Life Cycle is the theme of the 8th edition of the Paperless Lab Academy®, running online this year due to the pandemic.
Research has predicted that the global single-use bioprocessing market will exhibit a CAGR of 13.6 percent over the forecast period until 2025.
Application note: Expansion of human bone marrow-derived mesenchymal stem cells in BioBLU 0.3c single-use bioreactors
16 December 2016 | By Vincent Dufey, Aurélie Tacheny, Muriel Art and Françoise De Longueville, Eppendorf Application Technologies S.A., Namur, Belgium and Ulrike Becken, Eppendorf AG Bioprocess Center, Juelich, Germany
In this application note, Eppendorf discuss how the use of adult stem cells holds great promise for new cell-based therapies and drug discovery...
5 September 2016 | By Eppendorf
Within the EU Research and Innovation program Horizon 2020 the European Union is now funding the TECHNOBEAT research project with almost 6 million Euro...
31 May 2016 | By Eppendorf
Eppendorf's BioBLU 3f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts and fungi...